Subtype
Human Papillomavirus-Related Cervical Carcinoma
CI-CAN-00005537Explore in graph →
17 active trials
- NCIt
- C27675
Loading cancer entity…
Subtype
CI-CAN-00005537Explore in graph →
Clinical trials
45 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05639972 | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers | recruiting | Phase 1 / Phase 2 | 15 | Christian HinrichsOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT06319963 | A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer | recruiting | Phase 1 / Phase 2 | 72 | Theravectys S.A.INDUSTRY | 1 | Feb 2, 2026 | clinicaltrials |
| NCT05829629 |
| Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women |
| recruiting |
| Phase 1 |
| 20 |
| BlueSky Immunotherapies GmbHINDUSTRY |
| 1 |
| Feb 14, 2025 |
| clinicaltrials |
Data updated 23 days agoSource updated Jun 12, 2026source: clinicaltrials